Back to Search
HOSSEIN GHOFRANI, M.D.
M.D.
Internal Medicine Physician
NPI: 1447576236IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology Physician
Internal Medicine — Nephrology
Code: 207RN0300X
9991(SD)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
9991(SD)
Education
OTHER
Class of 2004
Research & Publications (20)
First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension.
PMID 19129292·Eur Respir J·2009
8-other
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia.
PMID 19010982·Eur Respir J·2009
7-preclinical
Updated evidence-based treatment algorithm in pulmonary arterial hypertension.
PMID 19555861·J Am Coll Cardiol·2009
6-review
Long-term outcome with intravenous iloprost in pulmonary arterial hypertension.
PMID 19251782·Eur Respir J·2009
3-trial
A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension.
PMID 19380626·Circulation·2009
8-other
The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice.
PMID 19617308·Am J Physiol Lung Cell Mol Physiol·2009
7-preclinical
The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies.
PMID 19335746·Eur J Clin Invest·2009
6-review
Noninvasive detection of early pulmonary vascular dysfunction in scleroderma.
PMID 19497725·Respir Med·2009
8-other
Future perspectives for the treatment of pulmonary arterial hypertension.
PMID 19555854·J Am Coll Cardiol·2009
6-review
Novel soluble guanylyl cyclase stimulator BAY 41-2272 attenuates ischemia-reperfusion-induced lung injury.
PMID 19074557·Am J Physiol Lung Cell Mol Physiol·2009
7-preclinical
Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension.
PMID 19071225·Pulm Pharmacol Ther·2009
4-observational
Heme oxygenase-2 and large-conductance Ca2+-activated K+ channels: lung vascular effects of hypoxia.
PMID 19498059·Am J Respir Crit Care Med·2009
7-preclinical
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
PMID 19095129·J Am Coll Cardiol·2008
4-observational
Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms.
PMID 19043010·Eur Respir J·2008
6-review
Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling.
PMID 18955668·Circulation·2008
4-observational
[Dana Point: what is new in the treatment of pulmonary hypertension?].
PMID 18814094·Dtsch Med Wochenschr·2008
6-review
Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.
PMID 19087359·BMC Pulm Med·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2020 Zonal Ave, IRD 806
Los Angeles, CA 90033 - Phone
- (323) 226-7307
Quick Facts
- NPI
- 1447576236
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile